| 摘要 |
<p>A novel, potent macrophage activating factor is prepared in vitro by treating human group-specific component, also known as human vitamin D-binding protein, with glycosidases. Group-specific component, which is isolated from retired blood by known procedures, is thus readily converted to a highly potent macrophage activating factor.</p> |
